Efficacy of iguratimod on mineral and bone disorders after kidney transplantation: a preliminary study

Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro

(2021) Akira Miyama et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study

(2021) Jun Tao et al.   Frontiers in Immunology

Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways

(2020) Chang-hong Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis

(2019) Charat Thongprayoon et al.   Archives of Osteoporosis

Molecular mechanisms and clinical application of Iguratimod: A review

(2019) Huihui Jiang et al.   BIOMEDICINE & PHARMACOTHERAPY

Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: its efficacy, radiographic changes, safety and predictors over two years’ treatment for Japanese rheumatoid arthritis patients

(2018) Koichiro Ishikawa et al.   Modern Rheumatology

T-614 Promotes Osteoblastic Cell Differentiation by Increasing Dlx5 Expression and Regulating the Activation of p38 and NF-κB

(2018) Jinglue Song et al.   Biomed Research International

Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol

(2018) Pieter Evenepoel et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis

(2017) Yusuke Sakaguchi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Iguratimod (T-614) suppresses RANKL-induced osteoclast differentiation and migration in RAW264.7 cells via NF-κB and MAPK pathways

(2016) Ke Gan et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation

(2016) Shun-Li Kan et al.   MEDICINE

A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation

(2016) Myles Wolf et al.   TRANSPLANTATION

Importance of Vascular Calcification in Kidney Transplant Recipients

(2014) Giuseppe Cianciolo et al.   AMERICAN JOURNAL OF NEPHROLOGY

Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial

(2014) Naoki Ishiguro et al.   Modern Rheumatology

Recovery Versus Persistence of Disordered Mineral Metabolism in Kidney Transplant Recipients

(2013) Pieter Evenepoel   SEMINARS IN NEPHROLOGY

Fracture Risk in Kidney Transplant Recipients

(2013) Kyla L. Naylor et al.   TRANSPLANTATION

Progression of coronary artery calcification in renal transplant recipients

(2011) Nurhan Seyahi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway

(2009) Sara Panizo et al.   CIRCULATION RESEARCH

Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation

(2008) P. Evenepoel et al.   Clinical Journal of the American Society of Nephrology